Myrddin Rees

Summary

Affiliation: The Ipswich Hospital NHS Trust
Country: UK

Publications

  1. ncbi request reprint Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients
    Myrddin Rees
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke, Hampshire, United Kingdom
    Ann Surg 247:125-35. 2008
  2. ncbi request reprint Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases
    Thomas R O'Rourke
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust, Basingstoke, United Kingdom
    Ann Surg Oncol 15:207-18. 2008
  3. doi request reprint Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Basingstoke, UK
    Dig Surg 25:406-12. 2008
  4. pmc Open liver resection for colorectal metastases: better short- and long-term outcomes in patients potentially suitable for laparoscopic liver resection
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Basingstoke, UK
    HPB (Oxford) 12:188-94. 2010
  5. doi request reprint Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust, Aldermaston Road, Basingstoke, Hampshire RG24 9NA, UK
    Surg Oncol 17:3-13. 2008
  6. ncbi request reprint Image of the month--pedunculated hepatocellular carcinoma
    Lucy Tzouliadis
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke, England
    Arch Surg 142:95. 2007
  7. pmc The impact of pre-operative serum creatinine on short-term outcomes after liver resection
    Thomas Armstrong
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust Basingstoke, Hampshire, UK
    HPB (Oxford) 11:622-8. 2009
  8. ncbi request reprint Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases
    Anthony Antoniou
    Imperial College London, Department of Biosurgery and Surgical Technology, St Mary s Hospital, London, UK
    Surgery 141:9-18. 2007
  9. ncbi request reprint Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2
    Demetra Mavri-Damelin
    The UCL Institute of Hepatology, Hampstead Campus, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Int J Biochem Cell Biol 39:555-64. 2007
  10. ncbi request reprint Comparison of a new fibrin sealant with standard topical hemostatic agents
    Myron Schwartz
    Department of Surgery, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Arch Surg 139:1148-54. 2004

Collaborators

  • Fenella K S Welsh
  • P P Tekkis
  • M E Schwartz
  • O M Jones
  • A G Heriot
  • N Heaton
  • Timothy G John
  • Thomas Armstrong
  • Thomas R O'Rourke
  • Anthony Antoniou
  • Demetra Mavri-Damelin
  • Lucy Tzouliadis
  • John Wells
  • Kandiah Chandrakumaran
  • Shinn Yeung
  • Russell Strong
  • Stephen Lynch
  • Jonathan Fawcett
  • Daryl Wall
  • Humphrey J F Hodgson
  • Ian Shaw
  • Henry S Tilney
  • Richard E Lovegrove
  • Sarah J Hulin
  • Leonard H Damelin
  • Simon Eaton
  • Clare Selden

Detail Information

Publications11

  1. ncbi request reprint Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients
    Myrddin Rees
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke, Hampshire, United Kingdom
    Ann Surg 247:125-35. 2008
    ..To identify risk factors associated with cancer-specific survival and develop a predictive model for patients undergoing primary hepatic resection for metastatic colorectal cancer...
  2. ncbi request reprint Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases
    Thomas R O'Rourke
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust, Basingstoke, United Kingdom
    Ann Surg Oncol 15:207-18. 2008
    ..However, there is lack of consensus regarding long-term effectiveness of hepatic resection for non-colorectal, non-neuroendocrine (NCNN) liver metastases...
  3. doi request reprint Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Basingstoke, UK
    Dig Surg 25:406-12. 2008
    ..This review aims to achieve consensus regarding the predictors of survival after hepatic resection for colorectal metastases and evaluate current predictive models of outcome...
  4. pmc Open liver resection for colorectal metastases: better short- and long-term outcomes in patients potentially suitable for laparoscopic liver resection
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Basingstoke, UK
    HPB (Oxford) 12:188-94. 2010
    ..This study compared short- and long-term outcomes in patients undergoing hepatectomy for colorectal metastases (CRM), who were suitable for either laparoscopic or open surgery...
  5. doi request reprint Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making
    Fenella K S Welsh
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust, Aldermaston Road, Basingstoke, Hampshire RG24 9NA, UK
    Surg Oncol 17:3-13. 2008
    ..This study aimed to develop a predictive index for quantifying the likelihood of a positive resection margin (R1) for patients undergoing hepatic resection for metastatic colorectal cancer...
  6. ncbi request reprint Image of the month--pedunculated hepatocellular carcinoma
    Lucy Tzouliadis
    Department of Hepatobiliary Surgery, North Hampshire Hospital, Aldermaston Road, Basingstoke, England
    Arch Surg 142:95. 2007
  7. pmc The impact of pre-operative serum creatinine on short-term outcomes after liver resection
    Thomas Armstrong
    Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Foundation Trust Basingstoke, Hampshire, UK
    HPB (Oxford) 11:622-8. 2009
    ..The aim of the present study was to determine whether raised pre-operative serum creatinine increased the risk of renal failure after liver resection...
  8. ncbi request reprint Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases
    Anthony Antoniou
    Imperial College London, Department of Biosurgery and Surgical Technology, St Mary s Hospital, London, UK
    Surgery 141:9-18. 2007
    ..The perioperative risk and long-term survival benefit of repeat hepatectomy for patients with liver metastases from colorectal cancer, compared with that of a first liver resection, has been reported with varying results in the literature...
  9. ncbi request reprint Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2
    Demetra Mavri-Damelin
    The UCL Institute of Hepatology, Hampstead Campus, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Int J Biochem Cell Biol 39:555-64. 2007
    ..This strategy could provide a cell source capable of urea synthesis, and hence ammonia detoxificatory function, which would be useful in a bio-artificial liver...
  10. ncbi request reprint Comparison of a new fibrin sealant with standard topical hemostatic agents
    Myron Schwartz
    Department of Surgery, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Arch Surg 139:1148-54. 2004
    ..Fibrin sealants represent an improvement over conventional topical hemostatic agents, because they contain components that actively form clot. However, most available agents contain nonhuman protein, which represents an immunologic risk...
  11. pmc Biopsy of potentially operable hepatic colorectal metastases is not useless but dangerous
    Oliver M Jones
    BMJ 329:1045-6. 2004